| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 51.998 | 54 |
| GSM780708 | Untreated after 4 days (C2_1) | 44.1834 | 23 |
| GSM780709 | Untreated after 4 days (C3_1) | 37.4644 | 2 |
| GSM780719 | Untreated after 4 days (C1_2) | 49.9804 | 48 |
| GSM780720 | Untreated after 4 days (C2_2) | 39.018 | 4 |
| GSM780721 | Untreated after 4 days (C3_2) | 47.024 | 37 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 44.2978 | 24 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 46.0394 | 32 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 41.8112 | 12 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 46.7092 | 35 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 45.1678 | 28 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 45.5044 | 30 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 41.0068 | 9 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 44.2512 | 23 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 47.3883 | 38 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 45.8106 | 31 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 45.6072 | 30 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 50.1328 | 49 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 45.1736 | 28 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 46.2056 | 33 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 41.8272 | 12 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 48.4296 | 43 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 49.2354 | 46 |